Matinas BioPharma Holdings, Inc. (MTNB)
NYSEAMERICAN: MTNB · Real-Time Price · USD
0.530
-0.037 (-6.59%)
Nov 5, 2024, 3:50 PM EST - Market open
MTNB Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 5, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 3 | 47 | 108 | 218 | 272 | 369 | |
| Market Cap Growth | -49.24% | -56.68% | -50.35% | -19.56% | -26.50% | 452.45% | |
| Enterprise Value | -8 | 32 | 80 | 169 | 217 | 345 | |
| Last Close Price | 0.57 | 10.81 | 25.00 | 50.50 | 68.00 | 113.50 | |
| PE Ratio | - | -2.05 | -5.16 | -8.96 | -11.52 | -18.01 | |
| PS Ratio | - | 42.86 | 34.01 | 6618.48 | 1714.82 | 4113.26 | |
| PB Ratio | 0.15 | 2.44 | 2.96 | 4.16 | 4.26 | 11.18 | |
| P/FCF Ratio | -2.22 | -3.03 | -5.41 | -14.11 | -15.63 | -25.48 | |
| P/OCF Ratio | -2.22 | -3.07 | -5.66 | -14.35 | -15.63 | -26.21 | |
| EV/Sales Ratio | - | 29.62 | 24.97 | 5133.74 | 1367.86 | 3842.74 | |
| EV/EBITDA Ratio | -1.50 | -1.39 | -3.29 | -6.93 | -9.06 | -18.56 | |
| EV/EBIT Ratio | -1.47 | -1.37 | -3.24 | -6.85 | -8.95 | -18.24 | |
| EV/FCF Ratio | -1.96 | -2.10 | -3.97 | -10.94 | -12.47 | -23.81 | |
| Debt / Equity Ratio | 0.17 | 0.18 | 0.11 | 0.09 | 0.06 | 0.13 | |
| Debt / FCF Ratio | -0.18 | -0.23 | -0.21 | -0.30 | -0.22 | -0.29 | |
| Asset Turnover | - | 0.03 | 0.06 | 0.00 | 0.00 | 0.00 | |
| Quick Ratio | 5.98 | 5.25 | 6.71 | 11.41 | 16.45 | 8.97 | |
| Current Ratio | 6.39 | 5.93 | 8.06 | 11.73 | 17.25 | 9.66 | |
| Return on Equity (ROE) | -97.59% | -82.11% | -47.11% | -40.07% | -46.39% | -70.63% | |
| Return on Assets (ROA) | -50.87% | -42.49% | -28.96% | -23.37% | -27.21% | -39.30% | |
| Return on Capital (ROIC) | -54.95% | -46.74% | -31.38% | -24.80% | -28.88% | -43.95% | |
| Earnings Yield | -804.99% | -48.84% | -19.36% | -10.66% | -8.27% | -4.70% | |
| FCF Yield | -628.51% | -32.99% | -18.49% | -7.09% | -6.40% | -3.92% | |
| Buyback Yield / Dilution | -3.80% | -0.21% | -3.16% | -6.75% | -35.61% | -48.00% | |
| Total Shareholder Return | -3.80% | -0.21% | -3.16% | -6.75% | -35.61% | -48.00% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.